Enabling patient specific medicines using 3D printing in hospitals and pharmacie...
Enabling patient specific medicines using 3D printing in hospitals and pharmacies
Uniform drug treatments are not always the best option for treating some patient populations – including children and the elderly. The industry now has extensive knowledge on the benefits of personalized medicines that take the ag...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
PID2020-112628RA-I00
DISEÑO INTEGRAL Y FABRICACION ADITIVA DE IMPLANTES POLIMERIC...
96K€
Cerrado
Sarcura
Cell Factory on chips: make Cell Therapies affordable and ac...
75K€
Cerrado
PTQ-10-02760
Estudio del comportamiento de nuevos API¿s para la fabricaci...
19K€
Cerrado
PTQ-15-07923
Desarrollo de bibliotecas de productos de interés biomédico...
54K€
Cerrado
PRE2018-083662
Precision medicine, target and drug design
93K€
Cerrado
Información proyecto PMed
Duración del proyecto: 24 meses
Fecha Inicio: 2023-08-23
Fecha Fin: 2025-08-31
Líder del proyecto
CURIFYLABS OY
No se ha especificado una descripción o un objeto social para esta compañía.
Presupuesto del proyecto
4M€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Uniform drug treatments are not always the best option for treating some patient populations – including children and the elderly. The industry now has extensive knowledge on the benefits of personalized medicines that take the age, metabolic and genetic differences of patients into account. However, until now there has not been a practical manufacturing solution to put this knowledge into wide-scale use.
CurifyLabs has created a technology called MiniLab to make high-quality 3D printing of personalized medicines available on site in the pharmacies and bring industry level standards to mass customisation of medicines. In this project we will finalize a standard process for developing 3D printing compatible formulations and quality control solutions. This will make MiniLab highly scalable across different therapeutic areas.